BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 2931451)

  • 1. Inhibitory effect of a human T cell hybrid factor on both cell growth and mixed lymphocyte reactivity. Correlation with class II molecule expression.
    Trucco M; Shaw S; Korngold R
    J Clin Invest; 1985 Sep; 76(3):1032-41. PubMed ID: 2931451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.
    Sztein MB; Steeg PS; Johnson HM; Oppenheim JJ
    J Clin Invest; 1984 Feb; 73(2):556-65. PubMed ID: 6230374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse T lymphocytes proliferative responses specific for human MHC products in mouse anti-human xenogeneic MLR.
    Yoshizawa K; Yano A
    J Immunol; 1984 Jun; 132(6):2820-9. PubMed ID: 6202762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.
    Broxmeyer HE; Juliano L; Lu L; Platzer E; Dupont B
    J Clin Invest; 1984 Apr; 73(4):939-53. PubMed ID: 6231314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunobiology of T cell responses to Mls-locus-disparate stimulator cells. II. Effects of Mls-locus-disparate stimulator cells on cloned, protein antigen-specific, Ia-restricted T cell lines.
    Katz ME; Janeway CA
    J Immunol; 1985 Apr; 134(4):2064-70. PubMed ID: 2579126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions. Role of HLA-DR antigens.
    Rossi GA; Zocchi E; Sacco O; Balbi B; Ravazzoni C; Damiani G
    Am Rev Respir Dis; 1986 Jan; 133(1):78-82. PubMed ID: 2935058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
    Masuyama J; Minato N; Kano S
    J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability.
    Santoli D; Francis MK; Matera L
    Nat Immun Cell Growth Regul; 1985; 4(2):103-12. PubMed ID: 3160933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
    J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules.
    Glimcher LH; Longo DL; Green I; Schwartz RH
    J Exp Med; 1981 Nov; 154(5):1652-70. PubMed ID: 6170721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation.
    Fierz W; Endler B; Reske K; Wekerle H; Fontana A
    J Immunol; 1985 Jun; 134(6):3785-93. PubMed ID: 3921611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
    Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
    Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DR antigens render interleukin-2-producer T lymphocytes sensitive to interleukin-1.
    Palacios R
    Scand J Immunol; 1981 Sep; 14(3):321-6. PubMed ID: 6173920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T cells directed against HLA-DR antigens and their surface proteins.
    Burakoff SJ; Clayberger C; Hemler M; Krensky AM; Reiss CS; Robbins E; Sanchez-Madrid F; Springer TA; Strominger JL; Ware CF
    Diagn Immunol; 1983; 1(3):116-9. PubMed ID: 6238749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of glioma cells to interferon-gamma: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating ability.
    Takiguchi M; Ting JP; Buessow SC; Boyer C; Gillespie Y; Frelinger JA
    Eur J Immunol; 1985 Aug; 15(8):809-14. PubMed ID: 2411569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenogeneic recognition of soluble and cell surface HLA class II antigens by proliferative murine T cells.
    Viguier M; Lotteau V; Charron D; Debré P
    Eur J Immunol; 1987 Nov; 17(11):1540-6. PubMed ID: 2960540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.